Seeking Alpha

Amgen (AMGN) agrees to acquire deCODE Genetics, which analyzes the links between the genome and...

Amgen (AMGN) agrees to acquire deCODE Genetics, which analyzes the links between the genome and susceptibility to disease, in a deal that values the Icelandic company at $415M. deCODE Genetics has discovered genetic risks for dozens of illnesses, including cardiovascular problems and cancer. With the transaction not requiring regulatory approval, Amgen expects it to close by the end of the month. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector